Myricetin supplementation decreases hepatic lipid synthesis and inflammation by modulating gut microbiotaWenlong Sun, Hong‐Fang Ji, Xinyu Li et al.|Cell Reports|2021Cited by 120
Short-chain fatty acids in nonalcoholic fatty liver disease: New prospects for short-chain fatty acids as therapeutic targetsXinyu Li, Yaling Zhu, Maozhang He et al.|Heliyon|2024Cited by 68
MicroRNA-185 regulates expression of lipid metabolism genes and improves insulin sensitivity in mice with non-alcoholic fatty liver diseaseXiaochen Wang, Xiaomin Liu, Xiaorong Zhan et al.|World Journal of Gastroenterology|2014Cited by 59
Anti-inflammatory effect of luteolin is related to the changes in the gut microbiota and contributes to preventing the progression from simple steatosis to nonalcoholic steatohepatitisWenlong Sun, Hong‐Fang Ji, Jing‐Wen Yang et al.|Bioorganic Chemistry|2021Cited by 54
Bidirectional and persistent immunomodulation of Astragalus polysaccharide as an adjuvant of influenza and recombinant SARS-CoV-2 vaccineDanping Zhao, Wei He, Xiuhong Chen et al.|International Journal of Biological Macromolecules|2023Cited by 47